Givaudan | GIVN - Ebitda

Aktienkurs
2,817.00
Täglich Wechseln
4.00 0.14%
Monatlich
-6.13%
Jährlich
-28.95%
Q1 Prognose
2,725.82




Ebitda Veränderung Datum
Air Liquide EUR 3.82B 205.4M 2025-12
Akzo Nobel EUR 385M 8M 2025-09
Anheuser-Busch USD 5.59B 1.27B 2025-09
Arkema EUR 310M 54M 2025-09
Associated British Foods GBP 956M 136M 2022-12
BASF EUR 1.54B 228M 2025-09
Bayer EUR 1.97B 457M 2025-12
Beiersdorf EUR 984M 147M 2025-06
British American Tobacco GBP 6.02B 200M 2024-06
Covestro EUR 242M 24M 2025-09
Croda International GBP 198.5M 4.7M 2025-06
Danone EUR 2.45B 149M 2025-06
Diageo GBP 3.53B 229M 2025-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Givaudan CHF 778M 195M 2025-12
Glanbia EUR 289.7M 28.1M 2025-01
Heineken EUR 2.93B 161M 2025-12
Henkel EUR 1.88B 139M 2024-12
International Flavors Fragrances USD 519M 33M 2025-09
Johnson Matthey GBP 325M 52M 2024-06
Kerry EUR 635.8M 83.6M 2024-12
Lonza CHF 1.01B 54M 2025-12
L'Oréal EUR 5.6B 587.6M 2025-06
Merck EUR 1.44B 263M 2025-12
Nestle CHF 9.09B 594M 2025-06
Pernod Ricard EUR 2.18B 997M 2024-12
Reckitt Benckiser GBP 1.95B 708M 2025-06
SGS CHF 774M 78M 2024-12
Sika AG CHF 1.07B 106.25M 2025-06
Solvay EUR 169M 63M 2025-12
Tate & Lyle GBP 215M 22M 2025-12
Umicore EUR 433M 63M 2025-06
Victrex GBP 49.1M 4M 2023-12